Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 30, 2021
[Dynamics of cognitive impairments during L-dopa therapy in Parkinson's disease]S B Ismailova, S V Prokopenko, D V Pokhabov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 18, 2021
[A novel approach to differential diagnosis of Parkinson's disease and essential tremor]D V Pokhabov, D D Pokhabov, V G Abramov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients]S E Khat'kova, D R Khasanova, L A Korenko, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 28, 2022
[Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)]S E Khatkova, O R Orlova, D V Pokhabov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2025
[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis]A N Boyko, V M Alifirova, Z A Goncharova, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]A N Boyko, V M Alifirova, I G Lukashevich, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]A N Boyko, V M Alifirova, I G Lukashevich, et al.Pageof 2